Prof. Wei R. Chen, co-inventor of IP-001, Stephenson Chair, professor, and interim director of the Stephenson School of Biomedical Engineering...

Robert Arch, SVP Corporate Development at Immunophotonics, Inc. will be attending the BIO CEO & Investor Conference which will be held on...

Tomas Hode, PhD, Co-Founder, CIO, and President of Immunophotonics, Inc. will be attending the SIO2025 Annual Scientific Meeting January 30...

Tomas Hode, PhD, President & CIO will attend the SPIE, the international society for optics and photonics conferences taking place...

Immunophotonics’ Tomas Hode, PhD (CIO and President) is attending Spectrum Conference, January 16 – 18, in Miami, Florida. Some of...

Our networking is well underway with investors and potential strategic partners for JPM2025 in San Francisco, January 13 – 16,...

Lu Alleruzzo, CEO and David Anderson, PhD, CSO of Immunophotonics, are excited to participate in the NCI SBIR Peer Learning...

Immunophotonics co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President will attend the AngioDynamics International Life Symposium taking...

Congratulations to Professor Wei Chen and his lab University of Oklahoma for their publication titled “Localized ablative immunotherapy enhances antitumor...

Siu Kit “Samuel” Lam, PhD, Senior Vice President of Science & Research at Immunophotonics, Inc. attended the SITC Immuno-Oncology Drug...